All terms in NCIT
| Label | Id | Description |
|---|---|---|
| TRK Receptor Family Fusion Positive | NCIT_C138156 | [Indicates that the expression of a fusion involving a TRK receptor family member has been detected in a sample.] |
| NTRK3 Fusion Positive | NCIT_C132236 | [Indicates that the expression of a NTRK3 fusion has been detected in a sample.] |
| NR3C1 Positive | NCIT_C132237 | [Indicates that NR3C1 expression has been detected in a sample.] |
| HLA-A*02:01/TP53aa264-272 Complex | NCIT_C132238 | [A protein complex comprised of the nine amino acid residues starting at position 264 and ending at position 272 of the wild-type form of cellular tumor antigen p53 bound to the cell surface antigen presenting molecule HLA class I histocompatibility antigen, A*02:01 alpha chain.] |
| Peptide/MHC Complex | NCIT_C18930 | [Peptide MHC Complexes consist of proteolytically-processed low molecular weight amino acid fragments of antigenic foreign proteins noncovalently bound to self MHC antigens and displayed on the surface of antigen presenting macrophages to helper T cells as an important part of an immune response.] |
| CD70 Positive | NCIT_C132239 | [Indicates that CD70 expression has been detected in a sample.] |
| Shared Anti-Idiotype AB-S002 | NCIT_C29420 | [A monoclonal antibody directed against a specific tumor-associated antigen (TAA). (NCI04)] |
| Shared Anti-Idiotype-AB-S003 | NCIT_C29421 | [A monoclonal antibody directed against a specific tumor-associated antigen (TAA). (NCI04)] |
| Shared Anti-Idiotype-AB-S004 | NCIT_C29422 | [A monoclonal antibody directed against a specific tumor-associated antigen (TAA). (NCI04)] |
| Shared Anti-Idiotype-AB-S005 | NCIT_C29423 | [A monoclonal antibody directed against a specific tumor-associated antigen (TAA). (NCI04)] |
| Shared Anti-Idiotype-AB-S006 | NCIT_C29424 | [A murine monoclonal anti-idiotype antibody that targets human B-cell lymphomas with potential antineoplastic activity. Shared Anti-Id-Ab-S006 binds to antigens on neoplastic B cells, resulting in tumor cell destruction by the reticuloendothelial system or cytotoxic T lymphocytes (CTL). (NCI04)] |
| CD79B Positive | NCIT_C132230 | [Indicates that CD78B expression has been detected in a sample.] |
| Shared Anti-Idiotype-AB-S008A | NCIT_C29425 | [A monoclonal antibody directed against a specific tumor-associated antigen (TAA). (NCI04)] |
| Shared Anti-Idiotype-AB-S011A | NCIT_C29426 | [A monoclonal antibody directed against a specific tumor-associated antigen (TAA). (NCI04)] |
| GATA1 Exon 3 Mutation | NCIT_C132232 | [A molecular genetic abnormality indicating the presence of a mutation in exon 3 of the GATA1 gene.] |
| GATA1 Gene Mutation | NCIT_C82340 | [A change in the nucleotide sequence of the GATA1 gene.] |
| Shared Anti-Idiotype-AB-S012 | NCIT_C29427 | [A monoclonal antibody directed against a specific tumor-associated antigen (TAA). (NCI04)] |
| GATA1 Exon 2 Mutation | NCIT_C132233 | [A molecular genetic abnormality indicating the presence of a mutation in exon 2 of the GATA1 gene.] |
| Shared Anti-Idiotype-AB-S016 | NCIT_C29428 | [A monoclonal antibody directed against a specific tumor-associated antigen (TAA). (NCI04)] |
| TFE3 Positive | NCIT_C132234 | [Indicates that TFE3 expression has been detected in a sample.] |